Drug Topics

APRIL 3, 2025

Bird flu cases total 70 US patients as more animals are infected.

Hospitals 519

Hospitals 519

STAT

APRIL 3, 2025

Hotlines that have fielded millions of calls from people — including new mothers — looking for mental health support or to quit smoking are in limbo after federal officials fired the workers who oversaw them.  Employees were cut from offices that fund prevention work on the local, state, and tribal level. Those include hotlines like the Maternal Mental Health Hotline run by the Health Resources and Services Administration, and another to help smokers quit using tobacco.

142

142

Drug Topics

APRIL 3, 2025

As over-the-counter birth control becomes increasingly available, pharmacists are uniquely positioned to bridge critical gaps in reproductive health care.

487

487

STAT

APRIL 3, 2025

LONDON — The U.K. government is starting to recognize that the country needs to change how it pays for medicines if it is to attract more investment from the pharmaceutical industry, a government official said Thursday.  The pharma industry has for several years complained about the scheme under which the National Health Service buys medicines, with drug companies having to pay a portion of their sales back to the government when drug spending increases past a certain level.

85

85

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

APRIL 3, 2025

As of April 2, 2025, liraglutide remained in shortage, with the drug first entering the FDA database on July 18, 2023.

FDA 423

FDA 423

The Checkup by Singlecare

APRIL 3, 2025

Telemedicine is defined as the remote delivery of healthcare services using a phone, tablet, or computer, according to the Centers for Disease Control and Prevention. Starting with the COVID-19 pandemic, telemedicine expanded rapidly and redefined the delivery of medical services in virtually every aspect of healthcare. Pharmacy is no exception. Telepharmacy utilizes technology to deliver pharmacy services in an innovative way, according to an article published in Integrated Pharmacy Research an

Department of Veterans Affairs 52

Department of Veterans Affairs Medication Labelling Labelling Communication 52

PharmaVoice

APRIL 3, 2025

What healthcare watchdogs have said about the far-reaching job cuts this week.

130

130

Drug Topics

APRIL 3, 2025

Previous research shows herpes zoster is associated with a higher long-term risk of subjective cognitive decline, with increased risk for men who carried APOE 4.

Vaccines 332

Vaccines 332

Pharmacy Times

APRIL 3, 2025

Notably, high levels of high-density lipoprotein cholesterol (HDL-C) were not associated with the risk of dementia following adjustments for triglyceride levels.

124

124

Drug Topics

APRIL 3, 2025

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

APRIL 3, 2025

Pharmacists can address micronutrient deficiencies, aiding those with type 2 diabetes as they face a higher risk.

122

122

Drug Topics

APRIL 3, 2025

Researchers wanted to understand the distribution of pneumococcal conjugate vaccine serotypes and how they have potential to impact pneumococcal disease severity and burden.

Vaccines 247

Vaccines 247

Fierce Healthcare

APRIL 3, 2025

Oz is now the head of more than 160 million Americans' health coverage, and enters the role at a time of major upheaval for the agency and its parent department.

116

116

Drug Topics

APRIL 3, 2025

Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.

190

190

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

APRIL 3, 2025

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as generic liraglutide through its weight loss platform.

116

116

Drug Topics

APRIL 3, 2025

Traditional approaches have typically relied on oral medications, which can expose the entire body to potentially harmful adverse effects.

190

190

Pharmacy Times

APRIL 3, 2025

Positive results from an interim analysis of the phase 3 ALIGN study bolstered atrasentan towards receiving accelerated approval for patients with immunoglobulin A nephropathy, a rare condition that can cause kidney failure.

FDA 114

FDA 114

STAT

APRIL 3, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning and happy Thursday.

104

104

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

APRIL 3, 2025

Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a unique outcomes-based payment model

92

92

STAT

APRIL 3, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, let’s get straight into all the news today.

96

96

Pharmacy Times

APRIL 3, 2025

This action makes inebilizumab the first and only FDA-approved treatment for adults with immunoglobulin G4-related disease (IgG4-RD).

FDA 86

FDA 86

Fierce Healthcare

APRIL 3, 2025

Fierce Healthcare talked to a dozen experts about what key changes the U.S. has gone through since COVID-19 became a pandemic. Here are their takeaways.

84

84

pharmaphorum

APRIL 3, 2025

BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class

78

78

Pharmacy Times

APRIL 3, 2025

No manufacturing or safety issues were identified, but the FDA stated the new drug application did not demonstrate efficacy in adequate and well-controlled studies.

FDA 65

FDA 65

pharmaphorum

APRIL 3, 2025

Novartis has claimed accelerated approval in the US for Vanrafia, one of a trio of drugs it hopes will revolutionise the treatment of IgA nephropathy.

FDA 66

FDA 66

Pharmacy Times

APRIL 3, 2025

Through increased utilization of multi-omic data, health care professionals can revolutionize the treatment paradigm of countless diseases.

65

65

Pharmaceutical Commerce

APRIL 3, 2025

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, describes the various conference sessions that she participated in.

59

59

Pharmacy Times

APRIL 3, 2025

Generics play a crucial role in mitigating drug shortages by offering a real alternative for 80% of drugs that are becoming increasingly unavailable in Italy.

65

65

Pharmaceutical Commerce

APRIL 3, 2025

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirsts chief medical officer, explains the rise in patients turning to DTC platforms following insurance denials.

Insurance 59

Insurance 59

Pharmacy Times

APRIL 3, 2025

The predictive tool may reveal the mechanisms underlying treatment resistance in patients with HER+ breast cancer.

65

65

Pharmaceutical Commerce

APRIL 3, 2025

The latest news for pharma industry insiders.

59

59

Pharmacy Times

APRIL 3, 2025

Panelists discuss how health care professionals use clear, tailored communication to explain antibody-drug conjugate (ADC) risks, benefits, and regimens. They provide education, address concerns, and ensure adherence through counseling and shared decision-making.

Communication 65

Communication 65

Pharmaceutical Technology

APRIL 3, 2025

At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early Parkinsons disease (PD).

52

52